Loading clinical trials...
Loading clinical trials...
Ocular damage is found in the 3rd rank of extra intestinal manifestations (MEI) Potentially serious functional complications (see uveitis and risk of blindness) requiring rapid management Rare uveitis...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Central Hospital, Nancy, France
NCT04844606 · Ulcerative Colitis, Ulcerative Colitis Chronic, and more
NCT07400757 · Thyroid Eye Disease, TED, Graves Ophthalmopathy
NCT06553053 · Crohn's Disease Relapse, Inflammatory Bowel Diseases
NCT06226883 · Inflammatory Bowel Diseases, Crohn's Disease
NCT05986136 · Inflammatory Bowel Diseases
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions